TC
MED icon

Trilogy Capital’s Medifast MED Stock Holding History

Trilogy Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,978
Closed -$223K – 277
2023
Q3 		$223K Sell
2,978
-316
-10% -$28K 0.02% 246
2023
Q2 		$309K Buy
3,294
+501
+18% +$44.6K 0.02% 226
2023
Q1 		$290K Buy
2,793
+1,035
+59% +$115K 0.02% 221
2022
Q4 		$203K Buy
+1,758
New +$205K 0.01% 240

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Trilogy Capital's MED Position: Q4 2023 in Review

Trilogy Capital sold out of Medifast (MED) in Q4 2023, closing a stake of 2,978 shares — an estimated $223K sold.

Trilogy Capital first reported a position in MED in Q4 2022 and held it in 4 quarters. The position peaked at $309K in Q2 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Trilogy Capital reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Trilogy Capital sold 2,978 Medifast shares in Q4 2023, an estimated $223K.
  • Trilogy Capital first reported a position in Medifast in Q4 2022 and held it in 4 quarters.
  • Trilogy Capital's Medifast position peaked at $309K in Q2 2023.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Trilogy Capital's 13F filing for Q4 2023, filed 12 Jan 2024.